Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Zanganeh Maky
Relationship:   Chief Executive Office...
City:   Sunnyvale
State:   CA
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   1,125,725    

Indirect Shares

  198,074      
Direct Value   $5,895,744    

Indirect Value

  $1,168,115      
Total Shares   1,323,799      
Total Value   $7,063,859      


Pulse Biosciences, Inc.
 $4,046,855 Summit Therapeutics Inc
 $1,848,890 Pulse Biosciences, Inc.
 $4,046,855 Summit Therapeutics Inc
 $1,848,890
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    11   
    0    

     Stock price went up :

    7   
    0    
     Stock price went down :
    4   
    0    
   
     Gain/Loss Ratio :
   1.8   
   0.0   
     Percentage Gain/Loss :
   51.2%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Pharmacyclics Inc PCYC Chief Operating Officer 2015-05-26 0 2015-05-26 0    Premium*  
            Pulse Biosciences, Inc. PLSE Director 2023-11-13 604,911 2023-11-13 148,074    Premium*  
            Summit Therapeutics Inc SMMT Chief Executive Office... 2024-03-27 520,814 2024-03-27 50,000    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
SMMT Summit Therapeutics Inc Chief Executive Officer   •       •      –    2024-03-27 4 B $3.71 $201,874 I/I 54,321 50,000 2.66 %
SMMT Summit Therapeutics Inc Chief Executive Officer   •       •      –    2024-03-27 4 B $3.72 $96,720 D/D 26,000 520,814 2.81 %
SMMT Summit Therapeutics Inc Chief Executive Officer   •       •      –    2024-03-26 4 B $3.75 $112,500 I/I 30,000 30,000 2.66 %
SMMT Summit Therapeutics Inc Chief Executive Officer   •       •      –    2023-12-12 4 B $2.07 $10,350 D/D 5,000 494,814 2.81 %
SMMT Summit Therapeutics Inc Chief Executive Officer   •       •      –    2023-12-11 4 OE $1.58 $498,776 I/I 315,681 24,889,479 0 -
SMMT Summit Therapeutics Inc Chief Executive Officer   •       •      –    2023-12-11 4 OE $1.44 $705,332 D/D 489,814 489,814 0 -
PLSE Pulse Biosciences, Inc. Director   •       •      –    2023-11-13 4 OE $2.14 $162,801 D/D 76,075 604,911 0 -
PLSE Pulse Biosciences, Inc. Director   •       •      –    2023-06-09 4 OE $2.05 $177,669 D/D 86,668 791,915 0 -
PLSE Pulse Biosciences, Inc. Director   •       •      –    2023-06-09 4/A OE $2.05 $177,669 D/D 86,668 528,836 0 -
SMMT Summit Therapeutics Inc Co-CEO & President   •       •      –    2023-03-08 4/A B $1.05 $24,703,396 I/I 23,527,044 9,884,095 2.66 -
SMMT Summit Therapeutics Inc Co-Chief Executive Officer   •       •      –    2023-03-08 4 B $1.05 $7,930,966 I/I 7,553,301 9,884,095 2.66 %
SMMT Summit Therapeutics Inc Co-Chief Executive Officer   •       •      –    2023-03-08 4 B $1.05 $16,772,430 D/D 15,973,743 23,395,269 2.81 %
SMMT Summit Therapeutics Inc Co-CEO & President   •       •      –    2022-12-06 4 A $0.00 $0 D/D 373,857 10,930,849 0 -
SMMT Summit Therapeutics Inc Co-CEO & President   •       •      –    2022-08-16 4 B $0.97 $5,455,961 I/I 5,624,702 3,135,466 2.66 %
SMMT Summit Therapeutics Inc Co-CEO & President   •       •      –    2022-08-16 4 B $0.97 $178,897 D/D 184,430 359,969 2.81 %
PLSE Pulse Biosciences, Inc. Director   –       •      –    2022-06-09 4 OE $0.00 $0 D/D 86,668 442,168 0 -
SMMT Summit Therapeutics Inc Chief Operating Officer   •       •      –    2021-05-12 4 B $5.24 $2,038,763 I/I 389,077 2,643,319 2.66 %
PLSE Pulse Biosciences, Inc. Director   –       •      –    2021-01-19 4 OE $7.01 $2,152 I/I 307 107,074 0 -
PLSE Pulse Biosciences, Inc. Director   –       •      –    2021-01-08 4 OE $7.01 $21,030 D/D 3,000 355,500 0 -
SMMT Summit Therapeutics Inc Director   –       •      –    2020-11-11 3 IO $0.00 $0 I/I 0 4,358,783 %
PLSE Pulse Biosciences, Inc. Director   –       •      –    2020-06-23 4 B $10.70 $12,767 I/I 1,193 106,767 2.1 %
PLSE Pulse Biosciences, Inc. Director   –       •      –    2020-06-17 4 B $7.01 $55,730 I/I 7,950 105,574 2.1 %
PLSE Pulse Biosciences, Inc. Director   –       •      –    2020-06-15 4 OE $7.01 $14,371 I/I 2,050 97,624 0 -
PLSE Pulse Biosciences, Inc. Director   –       •      –    2020-06-15 4 OE $7.01 $140,200 D/D 20,000 352,500 0 -
PLSE Pulse Biosciences, Inc. Director   –       •      –    2017-12-13 4 B $23.98 $26,378 I/I 1,100 95,574 2.1 -

  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed